Stoke Therapeutics is pioneering a new way to treat the underlying causes of severe genetic diseases by precisely upregulating protein expression.

Biotechnology

Stoke Therapeutics

Stoke Therapeutics' headquarters in Bedford, MA, United States

Edward M. Kaye

Jessica Blumstein

Isabel Aznarez

Tommy Leggett

Dawn Kalmar

Barry S. Ticho

Beth Mellen

Anne Christiansen

Naomi Muse

Jason Hoitt

Stephen Yu

Malini Viswanathan Ph.D

Katherine Pare Lefeber

Jonathan Allan

Joan Wood

Seth L. Harrison

Adrian Krainer

Arthur Levin

Julie Anne Smith

Arthur Tzianabos

Jennifer Burstein

The Research and Development team at Stoke Therapeutics is dedicated to advancing innovative therapies for severe genetic diseases by leveraging cutting-edge bioinformatics, medicinal chemistry, and in vitro pharmacology. This multidisciplinary group collaborates to design, test, and refine potential treatments, aiming to upregulate protein expression and address the root causes of these conditions, ultimately paving the way for transformative clinical applications.

Research and Development

This department oversees medical affairs, regulatory strategies, and communications to ensure compliance and effective market access for products.

Medical Affairs and Regulations

This department manages and oversees clinical trials to ensure compliance with regulations and the successful execution of research projects.

Clinical Trials

The Clinical Operations team at Stoke Therapeutics is responsible for overseeing the planning, execution, and management of clinical trials aimed at evaluating innovative treatments for severe genetic diseases. This team ensures compliance with regulatory standards, coordinates logistics, manages clinical data, and collaborates across departments to facilitate efficient trial processes, ultimately driving the development of new therapies from concept to clinical implementation.

Clinical Operations

The Clinical Operations team at Stoke Therapeutics is responsible for overseeing the execution and management of clinical trials. They ensure that studies are conducted efficiently and adhere to regulatory guidelines, while also managing data integrity and analysis. This team collaborates closely with medical and research professionals to drive the development of innovative treatments for genetic diseases, specifically focusing on ophthalmology and other therapeutic areas.

This department oversees the management and development of drug substances and drug products in the chemistry, manufacturing, and controls domain.

Stoke Therapeutics

Org chart

Board & advisors

Teams

Research and Development

Medical Affairs and Regulations

Clinical Trials

Clinical Operations

Clinical Operations

CMC Operations

Offices

Stoke Therapeutics

Org chart

Board & advisors

Teams

Research and Development

Medical Affairs and Regulations

Clinical Trials

Clinical Operations

Clinical Operations

CMC Operations

Offices

Related companies